- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
FDA has finalized changes to the prescribing and dispensing restrictions on the abortion pill, mifepristone, allowing licensed health care providers and certain pharmacies, including retail pharmacies, to dispense the drug, Danco Laboratories and GenBioPro, which manufacture mifepristone, announced Tuesday evening (Jan. 3).
Advertisement
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us